Social Sentiment Ticker Powered by AI

DOW/USD32,988.21bullish
SPX/USD4,243.13bullish
NDX/USD14,711.33bullish
AAPL/USD172.40bearish
GOOGL/USD132.43bearish
TSLA/USD246.53bearish
NVDA/USD435.17bearish
AMD/USD100.08bearish
COIN/USD72.48bearish
NFLX/USD376.75bearish
BTC/USD27,772.28neutral
ETH/USD1,650.29neutral
XRP/USD0.54neutral
DOGE/USD0.06neutral

Social Sentiment Ticker Powered by AI

DOW/USD32,988.21bullish
SPX/USD4,243.13bullish
NDX/USD14,711.33bullish
AAPL/USD172.40bearish
GOOGL/USD132.43bearish
TSLA/USD246.53bearish
NVDA/USD435.17bearish
AMD/USD100.08bearish
COIN/USD72.48bearish
NFLX/USD376.75bearish
BTC/USD27,772.28neutral
ETH/USD1,650.29neutral
XRP/USD0.54neutral
DOGE/USD0.06neutral
LOG IN / SIGN UP

Download App

0

Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution

September 19, 2023

2 weeks ago

Company intends to make cash distributions currently estimated to be between $5 million and $7 million, or $0.84 to $1.17 per share, to shareholders following shareholder approval and the filing of the certificate of dissolution Company intends to make cash distributions currently estimated to be between $5 million and $7 million, or $0.84 to $1.17 per share, to shareholders following shareholder approval and the filing of the certificate of dissolution

Continue Reading

Feed Topics

News

Feed Tags

Share this Feed News

Subscribe
Notify of

0 Comments

Inline Feedbacks
View all comments